loader2
NRI

Dec 20, 2024

Category

Equity

AUM (Cr.)

84.15

Exit Load (%)

0.00

Min Inv Lumpsum

5,000

Expense Ratio

0.00

Sharpe Ratio

29.77

Beta Ratio

0.00

Fund Manager

Karan Doshi

Inception Date

Feb 28, 2019

Risk Level

Very High

Investment Objective

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the Scheme will be realized.

Invest Now
S&P BSE Healthcare TRI

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - LIC MF Healthcare Fund - Regular (G) 3.1 20.96 46.79 18.73 23.24 20.74
Benchmark - S&P BSE Healthcare TRI -1.88 10.85 37 11.94 22.91 0
Category Average - BEST EQUITY PERFORMERS 2.3 3.1 25.86 19.51 21.56 16.4
Category Rank 5/8 6/8 6/8 7/8 7/8 8/8
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Nippon India US Equity Opportunities Fund (G) 33.9996 0.82 21.03 8.89 14.14 719.18 2.39 100.00 invest
Nippon India US Equity Opportunities Fund (IDCW) 33.9996 0.82 21.03 8.89 14.14 719.18 2.39 100.00 invest
SBI Healthcare Opportunities Fund (G) 429.2021 0.37 42.39 25.37 29.37 3,459.68 1.95 5,000.00 invest
SBI Healthcare Opportunities Fund (IDCW) 270.3752 0.37 42.39 25.37 29.37 3,459.68 1.95 5,000.00 invest
Quant Teck Fund - Regular (G) 13.3489 -3.00 27.40 0.00 0.00 442.10 2.39 5,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)		 4 Months Trends
Equity-Sun Pharma.Inds. Nov 30, 2024 8.30 9.87 1.16
Equity-Piramal Pharma Nov 30, 2024 6.11 7.26 0.10
Equity-Artemis Medicare Nov 30, 2024 5.60 6.66 17.30
Equity-Torrent Pharma. Nov 30, 2024 4.50 5.35 13.40
Equity-Syngene Intl. Nov 30, 2024 3.82 4.54 29.99
Equity-Glenmark Pharma. Nov 30, 2024 3.76 4.47 -4.58
Reverse Repo-TREPS Nov 30, 2024 3.70 4.40 17.18
Equity-Mankind Pharma Nov 30, 2024 3.64 4.32 -3.98
Equity-Neuland Labs. Nov 30, 2024 3.56 4.24 21.03
Equity-Cipla Nov 30, 2024 3.52 4.19 -1.15

latest news

LIC Mutual Fund announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme

LIC Mutual Fund has announced 24 December 2024 as the record date for the d...

Dec 21, 2024 09:13

LIC Mutual Fund announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme

LIC Mutual Fund has announced 24 October 2024 as the record date for the de...

Oct 22, 2024 09:38

LIC Mutual Fund announces Income Distribution cum Capital Withdrawal (IDCW) under its schemes

LIC Mutual Fund has announced 27 August 2024 as the record date for the dec...

Aug 23, 2024 09:46

LIC Mutual Fund announces change in Key Personnel

LIC Mutual Fund has announced that Ms. Jigna Shyamyani has been appointed a...

Aug 08, 2024 10:52

LIC Mutual Fund announces Income Distribution cum Capital Withdrawal (IDCW) under its scheme

LIC Mutual Fund has announced 29 July 2024 as the record date for the decla...

Jul 25, 2024 09:34

LIC MF Announces change in fund manager under Ten schemes

LIC Mutual Fund has announced change in fund manager under the following sc...

Jul 02, 2024 12:43

SCHEME DETAILS

AMC Name : LIC Mutual Fund
Fund Name : LIC MF Healthcare Fund - Regular (G)
Contact Persone : Karan Doshi
Registered Address : 4th Floor, Industrial InsuranceBuilding, Opp.Churchgate StatiMumbai 400 020.
Telephone No : 022-66016000
Fax No. : 022-22843660
Email : cs.co:licmf.com
Website : www.licmf.com